dc.contributor.author | O'Farrelly, Cliona | en |
dc.date.accessioned | 2010-05-19T09:39:59Z | |
dc.date.available | 2010-05-19T09:39:59Z | |
dc.date.issued | 2010 | en |
dc.date.submitted | 2010 | en |
dc.identifier.citation | Elizabeth J. Ryan, Megan Dring, Cliona M. Ryan, Carol McNulty, Nigel J. Stevenson, Matthew W. Lawless, John Crowe, Niamh Nolan, John E. Hegarty and Cliona O'Farrelly, A variant in the CD209 promoter is associated with the severity of liver disease in chronic Hepatitis C virus infection, Human Immunology, 71, 8, 2010, 829-832 | en |
dc.identifier.other | Y | en |
dc.identifier.uri | http://hdl.handle.net/2262/39598 | |
dc.description | PUBLISHED | en |
dc.description.abstract | CD209, a c-type lectin expressed by dendritic cells (DCs) acts as a pathogen recognition receptor. A single nucleotide polymorphism (SNP) in the promoter region of CD209 (-336 A/G; rs4804803) affects transcription and is associated with the severity of Tuberculosis and Dengue fever. As CD209 binds Hepatitis C Virus (HCV) glycoprotein-E2, we investigated this SNP in the context of chronic HCV infection. 131 Irish women who had received HCV contaminated Anti-D immunoglobulin and 79 healthy controls were genotyped. We found no association between rs4804803 and the risk of HCV chronicity. However, of those with chronic infection, possession of at least one g-allele was associated with more advanced liver disease, with significantly higher liver fibrosis scores and levels of alanine transaminase (ALT) observed. We conclude that rs4804803, a SNP in the CD209 promoter contributes to the severity of liver disease in chronic HCV infection. | en |
dc.format.extent | 829-832 | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | Human Immunology | en |
dc.relation.ispartofseries | 71 | en |
dc.relation.ispartofseries | 8 | en |
dc.rights | Y | en |
dc.subject | Hepatitis C Virus | en |
dc.subject | chronic viral infection | en |
dc.subject | Biochemistry | |
dc.subject | Biochemistry | |
dc.title | A variant in the CD209 promoter is associated with the severity of liver disease in chronic Hepatitis C virus infection | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/ofarrecl | en |
dc.identifier.rssinternalid | 66618 | en |
dc.subject.TCDTheme | Immunology, Inflammation & Infection | en |
dc.identifier.rssuri | http://dx.doi.org/10.1016/j.humimm.2010.05.007 | en |
dc.contributor.sponsor | Health Research Board (HRB) | en |